Wellness, Alcohol, Vitals, and Emotions

Recruiting now · Not applicable

Conditions studied: Alcohol Use

In brief

The goal of this clinical trial is to examine the effects of mindfulness based relapse prevention on self-regulation overtime and drinking in daily life through the use of wearable heart rate sensors during mindfulness groups and answering assessment questions 3 times per day during the course of treatment. The main questions that it aims to answer are: 1. What changes in self-regulation as measured through heart rate variability are observed during a mindfulness intervention and how do those self-regulatory changes affect drinking after treatment? 2. How do changes in heart rate variability affect drinking, craving, and negative affectivity in daily life? Participants will: 1. Answer questions related to their mood and drinking behaviors. 2. Wear their sensors during an 8-week treatment period with 1 group per week. 3. Answer questions 3 times a day during the treatment period. 4.) Return their sensors via a pre-stamped package and answer questions about their mood and drinking behaviors 3- and 6-months after the mindfulness groups end.

Key facts

Study ID

NCT06982443

Run by

University of New Mexico

People needed

120

Starts

2025-10-01

Expected to finish

2029-09-01

Last updated by the study team

2026-07-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Meet criteria for a moderate to severe alcohol use disorder within the previous 3-months.
• Able to attend group meetings at the time listed on the recruitment materials.
• Willing to wear a sensor for the 8-week intervention period and return the sensor after the immediate follow-up.
• Have a phone/tablet/computer with internet access.
• Be able to comprehend and consent to study requirements in English.
• Have access to a valid U.S. mailing address for receiving the HRV sensors and reside in the United States.

You may not qualify if…

• Current symptoms of psychosis or mania.
• Have a substance use disorder requiring a higher level of care than outpatient treatment (e.g., severe alcohol use disorder requiring inpatient detoxification).
• Have a history of pulmonary or cardiovascular disease that interferes with sensor data collection and HRV metrics (i.e., ectopic beats, arrythmia, congenital heart disease).

Where it is running

• University of New Mexico — Albuquerque, New Mexico, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.